Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Endogenous Retrovirus Derepression Drives Ectopic UGT2B17 Overexpression in Multiple Myeloma Cells: Molecular Sequelae and Pathophysiological Implications

Spyros Ioannis Papamichos, MD PhD, Eleftheria Lamprianidou, Chryssoula Kordella, Emmanouil Spanoudakis, Menelaos Konstantinos Papoutselis, Ioannis Kotsianidis, PhD

Blood (2017) 130 (Supplement 1): 4978.

https://doi.org/10.1182/blood.V130.Suppl_1.4978.4978

Published: 2017

Journal Articles

Absorption, Metabolism and Excretion of GBT440, a Novel Hemoglobin S (HbS) Polymerization Inhibitor for the Treatment of Sickle Cell Disease (SCD), in Healthy Male Subjects

Peter Rademacher, PhD, Athiwat Hutchaleelaha, PhD, Carla Washington, Josh Lehrer, Eleanor Ramos, MD

Blood (2016) 128 (22): 2487.

https://doi.org/10.1182/blood.V128.22.2487.2487

Published: 2016

Journal Articles

Deferiprone Pharmacokinetics with and without Iron Overload and in Special Patient Populations

Michael Spino, PharmD, John Connelly, PhD, Yu-Chung Tsang, PhD, Caroline Fradette, PhD, Fernando Tricta, MD

Blood (2015) 126 (23): 3365.

https://doi.org/10.1182/blood.V126.23.3365.3365

Published: 2015

Journal Articles

The Association of Gilbert's Syndrome with Hyperbilirubinaemia Occurring on Any of Imatinib, Dasatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia (CML)

Jeeyune Bahk, BSc, Simone Claudiani, MD, Richard M Szydlo, BSc, PhD, Sarmad Toma, BSc, Faisal Abdillah, BSc, Sandra Hing, BSc, Simona Deplano, MDPhD, Dragana Milojkovic, Jane F Apperley, MD, Letizia Foroni, MD PhD

Blood (2015) 126 (23): 2795.

https://doi.org/10.1182/blood.V126.23.2795.2795

Published: 2015

Journal Articles

Pharmacokinetics, Metabolism and Excretion Of Idelalisib

Feng Jin, PhD, Michelle Robeson, ND, Huafeng Zhou, PhD, Ellen Kwan, Srini Ramanathan, PhD

Blood (2013) 122 (21): 5570.

https://doi.org/10.1182/blood.V122.21.5570.5570

Published: 2013

Journal Articles

A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1

Hiba A Zahreddine, Biljana Culjkovic-Kraljacic, PhD, Sarit Assouline, MD, Abdellatif Amri, Patrick Gendron, M.Sc., Andrea A. Romeo, PhD, Stephen Morris, PhD, James Jaquith, PhD, Gregory Cormack, Eftihia Cocolakis, PhD, Julie Bergeron, MD, Leandro Cerchietti, MD, Brian Leber, MD, Wilson H. Miller, Jr., MD, PhD, Katherine LB. Borden, PhD

Blood (2013) 122 (21): 821.

https://doi.org/10.1182/blood.V122.21.821.821

Published: 2013

Journal Articles

Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia

Michaela Gruber, Judith Bellemare, Gregor Hoermann, Andreas Gleiss, Edit Porpaczy, Martin Bilban, Trang Le, Sonja Zehetmayer, Christine Mannhalter, Alexander Gaiger, Medhat Shehata, Karin Fleiss, Cathrin Skrabs, Éric Lévesque, Katrina Vanura, Chantal Guillemette, Ulrich Jaeger

Blood (2013) 121 (7): 1175–1183.

https://doi.org/10.1182/blood-2012-08-447359

Published: 2013

Includes: Supplemental data

Journal Articles

Clinical Proof of Concept Trial of Oral Ciclopirox Olamine in Patients with Relapsed/Refractory Hematologic Malignancy

Mark D. Minden, MD, PhD, FRCPC, Donna E. Hogge, MD, PhD, FRCPC, Scott Weir, PharmD, PhD, Jim Kasper, MS, Lavonne Patton, PhD, Yulia Jitkova, PhD, Marcela Gronda, MSc, Rose Hurren, BSc, Lian Rajewski, Kevin Schorno, MBA, Hong Chang, Joseph M. Brandwein, MD, Vikas Gupta, MD, FRCP, FRCPath, Andre C. Schuh, MD, FRCPC, Suzanne Trudel, MD, MSC, FRCPC, Karen W.L. Yee, MD, FRCP, Greg Reed, Aaron D Schimmer, MD, PhD

Blood (2012) 120 (21): 1372.

https://doi.org/10.1182/blood.V120.21.1372.1372

Published: 2012

Journal Articles

Pharmacogenetic Study of Deferasirox, An Iron Chelating Agent

Hyoung Jin Kang, Ji Won Lee, Ji-Yeob Choi, Nam Hee Kim, Mi Kyung Jang, Chang-Woo Yeo, Sang-Seop Lee, Eun Jong Han, Hyery Kim, Kyung Duk Park, Hee Young Shin, Jae-Gook Shin, Hyo Seop Ahn

Blood (2010) 116 (21): 2060.

https://doi.org/10.1182/blood.V116.21.2060.2060

Published: 2010

Journal Articles

Deferiprone Is Associated with Lower Serum Ferritin (SF) Relative to Liver Iron Concentration (LIC) Than Deferoxamine and Deferasirox- Implications for Clinical Practice

Ai Leen Ang, MBBS, Farrukh T Shah, MD, Bernard A Davis, MD, Alison Thomas, MBBCh, BA, Govin Murugachandran, MBBS, BSc, Jeevan Kumuradevan, MBChB, Maciej W Garbowksi, LekMed, John B Porter, MD

Blood (2010) 116 (21): 4246.

https://doi.org/10.1182/blood.V116.21.4246.4246

Published: 2010

Journal Articles

Pharmacokinetics of Mycophenolic Mofetil and Metabolites in Allogeneic Transplant: Determination of Maximum Dose Schedule and Route of Administration.

Chenthil Rathnasabapathy, MD, Kathleen West, Ph.D, Gerald Fetterly, Ph.D, Minocher Battiwalla, MD, Shannon L Smiley, MD, Theresa Hahn, PhD, Karen Brown, NP, Karen Arnold, NP, Margaret Syta, NP, Pamela Paplham, NP, Joann Liu, NP, Philip L. McCarthy, MD

Blood (2009) 114 (22): 2276.

https://doi.org/10.1182/blood.V114.22.2276.2276

Published: 2009

Journal Articles

Morphine Pharmacokinetics in Sickle Cell Disease: Implications for Pain Management.

Deepika S. Darbari, Michael Neely, MD, John VandenAnker, MD, Sohail R Rana, MD

Blood (2009) 114 (22): 2574.

https://doi.org/10.1182/blood.V114.22.2574.2574

Published: 2009

Journal Articles

Effects of Imatinib on the Pharmacokinetics of Acetaminophen in Korean Patients with Chronic Myelogenous Leukemia (CML)

Dong-Wook Kim, MD, PhD, Sa-Hee Park, Yu Jin, MS, Michael Hayes, PhD, Yanfeng Wang, PhD

Blood (2008) 112 (11): 5056.

https://doi.org/10.1182/blood.V112.11.5056.5056

Published: 2008

Journal Articles

Effect of Deferasirox on Midazolam Pharmacokinetics.

Caroline Arrowsmith-Bensasson, Lisa Rojkjaer, Venkat Sethuraman, Andrej Skerjanec

Blood (2007) 110 (11): 3826.

https://doi.org/10.1182/blood.V110.11.3826.3826

Published: 2007

Journal Articles

UGT1A8 and UGT1A9 as Molecular Determinants of Mycophenolate Mofetil (MMF) Pharmacokinetics.

Eric Levesque, MD, PhD, Robert Delage, MD,MSC, Marie-Odile Benoit Biancamano, MSC, Felix Couture, MD, Chantal Guillemette, PhD

Blood (2006) 108 (11): 3191.

https://doi.org/10.1182/blood.V108.11.3191.3191

Published: 2006

Journal Articles

Bcl-2 Antagonist ApoGossypol (NSC736630) Displays Single-Agent Activity in Bcl-2 Transgenic Mice and Has Superior Efficacy and Pharmacology with Less Toxicity Compared to Gossypol (NSC19048).

Shinichi Kitada, MD, PhD, Lee Jia, Ph.D., Lori C. Coward, Ph.D., Greg S. Gorman, Ph.D., Patricia Noker, Ph.D., Maurizio Pellecchia, Ph.D., John C. Reed, M.D., Ph.D.

Blood (2006) 108 (11): 2487.

https://doi.org/10.1182/blood.V108.11.2487.2487

Published: 2006

Journal Articles

Pharmacogenomics of Deferiprone Metabolism.

Eden V. Haverfield, PhD, David J. Weatherall, MD, Andrea Yoder Graber, BA, Jacqueline Ramirez, MS, Mark J. Ratain, MD

Blood (2005) 106 (11): 2703.

https://doi.org/10.1182/blood.V106.11.2703.2703

Published: 2005

Journal Articles

Single Nucleotide Polymorphism (SNP) Discovery within the UGT1A Gene Complex: Allelic Frequencies and Ethnic Differences.

Jeeranut Sawattep, Thad A. Howard, MS, Noppawan P. Morales, PhD, Yupin Sanvarinda, PhD, Pranee Fucharoen, PhD, Suthat Fucharoen, MD PhD, Russell E. Ware, MD PhD

Blood (2004) 104 (11): 3780.

https://doi.org/10.1182/blood.V104.11.3780.3780

Published: 2004

NARROW

Endogenous Retrovirus Derepression Drives Ectopic UGT2B17 Overexpression in Multiple Myeloma Cells: Molecular Sequelae and Pathophysiological Implications

Absorption, Metabolism and Excretion of GBT440, a Novel Hemoglobin S (HbS) Polymerization Inhibitor for the Treatment of Sickle Cell Disease (SCD), in Healthy Male Subjects

Deferiprone Pharmacokinetics with and without Iron Overload and in Special Patient Populations

The Association of Gilbert's Syndrome with Hyperbilirubinaemia Occurring on Any of Imatinib, Dasatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia (CML)

Pharmacokinetics, Metabolism and Excretion Of Idelalisib

A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1

Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia

Clinical Proof of Concept Trial of Oral Ciclopirox Olamine in Patients with Relapsed/Refractory Hematologic Malignancy

Pharmacogenetic Study of Deferasirox, An Iron Chelating Agent

Deferiprone Is Associated with Lower Serum Ferritin (SF) Relative to Liver Iron Concentration (LIC) Than Deferoxamine and Deferasirox- Implications for Clinical Practice

Pharmacokinetics of Mycophenolic Mofetil and Metabolites in Allogeneic Transplant: Determination of Maximum Dose Schedule and Route of Administration.

Morphine Pharmacokinetics in Sickle Cell Disease: Implications for Pain Management.

Effects of Imatinib on the Pharmacokinetics of Acetaminophen in Korean Patients with Chronic Myelogenous Leukemia (CML)

Effect of Deferasirox on Midazolam Pharmacokinetics.

UGT1A8 and UGT1A9 as Molecular Determinants of Mycophenolate Mofetil (MMF) Pharmacokinetics.

Bcl-2 Antagonist ApoGossypol (NSC736630) Displays Single-Agent Activity in Bcl-2 Transgenic Mice and Has Superior Efficacy and Pharmacology with Less Toxicity Compared to Gossypol (NSC19048).

Pharmacogenomics of Deferiprone Metabolism.

Single Nucleotide Polymorphism (SNP) Discovery within the UGT1A Gene Complex: Allelic Frequencies and Ethnic Differences.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only